The Ontario Genomics Institute and Invitrogen co-hosted a symposium entitled 'Genome 2.0: New frontiers in epigenomics' held at the MaRS Centre in Toronto, Ontario.  This one day symposium addressed epigenetic regulation of gene expression with a special focus on chromatin biology, DNA methylation, non-coding RNAs and technology development. 

Click below to access the presentations from the event:

The roles of histone modifications in gene transcription 
Jerry Workman, Stowers Institute for Medical Research

How does the environment sculpt our genome?
Moshe Szyf, PhD, McGill University

MicroRNA networks regulated during neural stem cell differentiation
Loyal Goff, W.M. Keck Center for Collaborative Neuroscience, Rutgers University

A microRNA analysis platform identifies miRNAs involved in heart development and disease
Christopher Adams, Invitrogen Corporation

Epigenome-wide profiling unveils DNA modification changes in major psychiatric disease.
Art Petronis, The Krembil Family Epigenetics Laboratory, Centre for Addiction and Mental Health and University of Toronto

Epigenomic Technologies Panel Discussion
Moderated by Art Petronis, The Krembil Family Epigenetics Laboratory, Centre for Addiction and Mental Health and University of Toronto

The scientific chair for the event was Dr. Rosanna Weksberg, MD, PhD, The Hospital for Sick Children, Toronto, Ontario.